NCAPD2 is a favorable predictor of prognostic and immunotherapeutic biomarker for multiple cancer types including lung cancer

被引：0
|
作者：
Linyuan Feng
Yang Yang
Zhenhua Lin
Minghua Cui
Aihua Jin
Aili Cui
机构：
[1] Yanbian University Hospital,Key Laboratory of Pathobiology of High Frequency Oncology in Ethnic Minority Areas
[2] Yanbian University,undefined
[3] State Ethnic Affairs Commission,undefined
来源：
Genes and Environment | / 46卷
关键词：
NCAPD2; Prognosis; Immune infiltration; Tumor microenvironment; Bioinformatics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Correction: NCAPD2 is a favorable predictor of prognostic and immunotherapeutic biomarker for multiple cancer types including lung cancer
    Linyuan Feng
    Yang Yang
    Zhenhua Lin
    Minghua Cui
    Aihua Jin
    Aili Cui
    Genes and Environment, 46
  • [2] NCAPD2 is a favorable predictor of prognostic and immunotherapeutic biomarker for multiple cancer types including lung cancer (vol 46, 2, 2024)
    Feng, Linyuan
    Yang, Yang
    Lin, Zhenhua
    Cui, Minghua
    Jin, Aihua
    Cui, Aili
    GENES AND ENVIRONMENT, 2024, 46 (01)
  • [3] NCPAD2 is a favorable predictor of prognostic and immunotherapeutic biomarker for multiple cancer types including lung cancer
    Feng, Linyuan
    Yang, Yang
    Lin, Zhenhua
    Cui, Minghua
    Jin, Aihua
    Cui, Aili
    GENES AND ENVIRONMENT, 2024, 46 (01)
  • [4] Pan-Cancer Analysis Shows that KIFC2 is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Bladder Cancer
    Zhang, Helin
    Zhang, Xingxing
    Zhang, Yuelin
    Han, Dali
    Ha, Hualan
    Zhang, Biao
    Shang, Panfeng
    MOLECULAR BIOTECHNOLOGY, 2024, 67 (4) : 1641 - 1658
  • [5] Pan-cancer analysis shows that IBSP is a potential prognostic and immunotherapeutic biomarker for multiple cancer types including osteosarcoma
    Pan, Boyu
    Cheng, Xiaoyun
    Tan, Wei
    Liu, Renfeng
    Wu, Xin
    He, Jinpeng
    Fan, Qizhi
    Zhang, Yan
    Cheng, Jun
    Deng, Youwen
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [6] Pan-Cancer analysis shows that ACO2 is a potential prognostic and immunotherapeutic biomarker for multiple cancer types including hepatocellular carcinoma
    Wang, Zhen
    Zheng, Wanqun
    Chen, Zhen
    Wu, Shilun
    Chang, Haoxiao
    Cai, Ming
    Cai, Heping
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [7] Pan-cancer analysis shows that TNFSF4 is a potential prognostic and immunotherapeutic biomarker for multiple cancer types including liver cancer
    Deng, Zhaoda
    Li, Lincheng
    Meng, Zihe
    Zeng, Guineng
    Cao, Rui
    Liu, Rong
    BMC CANCER, 2025, 25 (01)
  • [8] Pan-Cancer Analysis Shows That ALKBH5 Is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Gliomas
    Wei, Cheng
    Wang, Bo
    Peng, Dazhao
    Zhang, Xiaoyang
    Li, Zesheng
    Luo, Lin
    He, Yingjie
    Liang, Hao
    Du, Xuezhi
    Li, Shenghui
    Zhang, Shu
    Zhang, Zhenyu
    Han, Lei
    Zhang, Jianning
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [9] Pan-Cancer Analysis Reveals SOX2 as a Promising Prognostic and Immunotherapeutic Biomarker Across Various Cancer Types, Including Pancreatic Cancer
    Ding, Yuntao
    Wang, Huizhi
    Wang, Qiaowei
    Jiang, Han
    Li, Zhangzuo
    Yu, Zhengyue
    Wang, Qi
    Xu, Min
    JOURNAL OF CANCER, 2024, 15 (01): : 251 - 274
  • [10] NCAPD2 serves as a potential prognostic biomarker for lung adenocarcinoma and promotes cell proliferation, migration, invasion and cell cycle in vitro
    Wu, Peiling
    Zhao, Lifang
    Zhang, Hongyan
    Lou, Yueyan
    Chen, Dongfang
    Xue, Shan
    Liu, Xueqing
    Jiang, Handong
    ONCOLOGY RESEARCH, 2024, 32 (09) : 1439 - 1452
12345